Clinical trials
Phase 2 Myelodysplastic Syndromes trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 3 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 47 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Groupe Francophone des Myelodysplasies | 5 |
| Colorado Blood Cancer Institute | 2 |
| Herbert Irving Comprehensive Cancer Center | 2 |
| Peking University People's Hospital | 2 |
| Shandong University | 2 |
| Tel-Aviv Sourasky Medical Center | 2 |
| ALZA | 1 |
| Affiliated Hospital to Academy of Military Medical Sciences | 1 |
| Anhui Provincial Hospital | 1 |
| Arno Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 47 |
| Leukemia, Myeloid, Acute | 16 |
| Leukemia | 10 |
| Lymphoma | 8 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 8 |
| Multiple Myeloma | 7 |
| Anemia, Refractory, with Excess of Blasts | 6 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 6 |
| Burkitt Lymphoma | 5 |
| Lymphoma, Non-Hodgkin | 5 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.